Seagen mum on Merck buyout rumors as it bats for blockbuster with Adcetris
Amgen bond offering to help fund Horizon Therapeutics acquisition
After several flops, Merck exec stands by aggressive Keytruda prostate cancer program
GSK vaccine R&D head touts consistency of RSV data
*please scroll down for all the latest news*
